News &amp; Updates

Treatment with focal high-intensity focused ultrasound (FHIFU) for patients with localized clinically significant prostate cancer is effective and safe, demonstrating acceptable oncologic and functional outcomes in the short term as well as minimal complications, according to a study, noting that patient selection is essential.

High-intensity focused ultrasound safe, effective for localized prostate cancer

Small bowel adenocarcinoma in coeliac disease: Is the risk real?

Individuals with coeliac disease are at higher risk of developing small bowel adenocarcinoma or adenomas compared with those who do not have the immune disorder, a study has shown. However, the absolute risks of these malignancies are small.

Small bowel adenocarcinoma in coeliac disease: Is the risk real?

FLIPI score, number of lines of treatment impact survival in follicular lymphoma patients

Undergoing more lines of treatment and having a higher Follicular Lymphoma International Prognostic Index (FLIPI) score appear to be associated with worse survival in FL patients, a recent study has shown.

FLIPI score, number of lines of treatment impact survival in follicular lymphoma patients

Follow guidelines for safe delivery of blinatumomab in leukaemia patients: study

Institutional guidelines in place are necessary to facilitate a safe and effective delivery of blinatumomab in patients with relapsed/refractory acute lymphoblastic leukaemia, suggests a study.

Follow guidelines for safe delivery of blinatumomab in leukaemia patients: study

SNPs may be useful biomarkers for AML risk

Single-nucleotide polymorphisms (SNPs) on the IL13 and VEGFA genes are associated with the risk of developing acute myeloid leukaemia (AML), reports a recent study.

SNPs may be useful biomarkers for AML risk

Metformin use may reduce CRC risk

14 Aug 2020 by

Metformin treatment in patients with type 2 diabetes (T2D) may have an added benefit – reduction in colorectal cancer (CRC) or colorectal adenoma incidence, a recent meta-analysis suggested.

Metformin use may reduce CRC risk

Low bleeding, VTE rates after 1-year edoxaban in real-world study

14 Aug 2020 by

The overall rates of bleeding and recurrent venous thromboembolism (VTE) were low across various subgroups after 12 months of edoxaban treatment in routine clinical practice, according to a non-interventional, post-authorization safety study of edoxaban — ETNA-VTE* presented during the ISTH 2020 Meeting.

Low bleeding, VTE rates after 1-year edoxaban in real-world study

Pharmacist-led medication reconciliation improves drug safety in patients initiating chemotherapy

Medication change is common among cancer patients, according to a study, noting that a brief oncology pharmacist-led medication reconciliation (PMR) can help prevent prescribing and administration errors, hence improving drug safety.

Pharmacist-led medication reconciliation improves drug safety in patients initiating chemotherapy

Self-management app eases cancer-related fatigue

14 Aug 2020 by

Untire, a self-management and mobile health app, may help ease cancer-related fatigue (CRF) and improve quality of life (QoL) among patients and survivors, according to a new study.

Self-management app eases cancer-related fatigue

Men with reduced fertility at risk of testicular, prostate cancers

Male infertility is linked to increased susceptibility to malignancies in the testicles or prostate, as shown in a study.

Men with reduced fertility at risk of testicular, prostate cancers